This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1999 Oct;48(4):471-80.

doi: 10.1046/j.1365-2125.1999.00026.x.

Acetylcholinesterase inhibitors in Alzheimer's disease

B M McGleenon¹, K B Dynan, A P Passmore

Affiliations

PMID: 10583015
PMCID: PMC2014378
DOI: 10.1046/j.1365-2125.1999.00026.x

Review

Acetylcholinesterase inhibitors in Alzheimer's disease

B M McGleenon et al. Br J Clin Pharmacol. 1999 Oct.

. 1999 Oct;48(4):471-80.

doi: 10.1046/j.1365-2125.1999.00026.x.

Authors

B M McGleenon¹, K B Dynan, A P Passmore

Affiliation

¹ Department of Geriatric Medicine, The Queen's University of Belfast, Belfast.

PMID: 10583015
PMCID: PMC2014378
DOI: 10.1046/j.1365-2125.1999.00026.x

No abstract available

PubMed Disclaimer

Similar articles

Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J. Wilkinson DG, et al. Drugs Aging. 2004;21(7):453-78. doi: 10.2165/00002512-200421070-00004. Drugs Aging. 2004. PMID: 15132713 Review.
Treating Alzheimer's disease with cholinesterase inhibitors: what have we learned so far?
Feldman H. Feldman H. Int Psychogeriatr. 2002;14 Suppl 1:3-5. doi: 10.1017/s1041610203008639. Int Psychogeriatr. 2002. PMID: 12636177 No abstract available.
Questions about donepezil.
Elie LM, Cole MG. Elie LM, et al. CMAJ. 1998 Apr 21;158(8):1014-5. CMAJ. 1998. PMID: 9580729 Free PMC article. No abstract available.
The role of acetylcholinesterase in the pathogenesis of Alzheimer's disease.
Rees TM, Brimijoin S. Rees TM, et al. Drugs Today (Barc). 2003 Jan;39(1):75-83. doi: 10.1358/dot.2003.39.1.740206. Drugs Today (Barc). 2003. PMID: 12669110 Review.
Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.
Martinez A, Castro A. Martinez A, et al. Expert Opin Investig Drugs. 2006 Jan;15(1):1-12. doi: 10.1517/13543784.15.1.1. Expert Opin Investig Drugs. 2006. PMID: 16370929 Review.

See all similar articles

Cited by

Therapeutic potential of blackberry extract in the preventing memory deficits and neurochemical alterations in the cerebral cortex, hippocampus and cerebellum of a rat model with amnesia.
de Mello JE, Luduvico KP, Dos Santos A, Teixeira FC, de Souza Cardoso J, de Aguiar MSS, Cunico W, Vizzotto M, Stefanello F, Spanevello R. de Mello JE, et al. Metab Brain Dis. 2023 Apr;38(4):1261-1272. doi: 10.1007/s11011-023-01175-w. Epub 2023 Feb 3. Metab Brain Dis. 2023. PMID: 36735154
Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer's Disease.
Volpato D, Holzgrabe U. Volpato D, et al. Molecules. 2018 Dec 7;23(12):3230. doi: 10.3390/molecules23123230. Molecules. 2018. PMID: 30544533 Free PMC article. Review.
An Investigation of the Altered Textural Property in Woody Breast Myopathy Using an Integrative Omics Approach.
Welter AA, Wu WJ, Maurer R, O'Quinn TG, Chao MD, Boyle DL, Geisbrecht ER, Hartson SD, Bowker BC, Zhuang H. Welter AA, et al. Front Physiol. 2022 Mar 17;13:860868. doi: 10.3389/fphys.2022.860868. eCollection 2022. Front Physiol. 2022. PMID: 35370787 Free PMC article.
In-vitro and in-vivo validation of ethnopharmacological uses of methanol extract of Isodon rugosus Wall. ex Benth. (Lamiaceae).
Janbaz KH, Arif J, Saqib F, Imran I, Ashraf M, Zia-Ul-Haq M, Jaafar HZ, De Feo V. Janbaz KH, et al. BMC Complement Altern Med. 2014 Feb 22;14:71. doi: 10.1186/1472-6882-14-71. BMC Complement Altern Med. 2014. PMID: 24559094 Free PMC article.
Wet or dry: translatable "water mazes" for mice and humans.
Higa KK, Young JW, Geyer MA. Higa KK, et al. J Clin Invest. 2016 Feb;126(2):477-9. doi: 10.1172/JCI86071. Epub 2016 Jan 19. J Clin Invest. 2016. PMID: 26784538 Free PMC article.

See all "Cited by" articles

References

1. Khann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34:939–944. - PubMed
1. Katzman R, Saitoh T. Advances in Alzheimer’s Disease. FASEB J. 1991;5:278–286. - PubMed
1. Becker RE. In: Cholinergic Basis of Alzheimer Therapy. Becker RE, Giacobini E, editors. Boston: Berkhauser; 1991. pp. 1–22. Therapy of the cognitive deficit in Alzheimer’s disease; the cholinergic system.
1. Cutler NR, Sramek JJ, Veroff AE. Alzheimer’s Disease. Chichester: John Wiley and Sons; 1994.
1. Becker RE, Giacobini E. Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer type; clinical pharmacological and therapeutic aspects. Drug Dev Res. 1988;12:163–195.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information